Anlotinib Followed by Transarterial Chemoembolization and Radiofrequency Ablation is a Safe and Effective Initial Treatment for Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus: A Retrospective Case Series Study
Journal of Cancer Research and Therapeutics（2021）
Key words
Anlotinib,hepatocellular carcinoma,portal vein tumor thrombus,radiofrequency ablation,transarterial chemoembolizationa
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined